Search
for
Sort by
Research 61–90 of 316
- (PNM-35) Recurrent priapism in a sickle cell disease patient treated with gonadotropin-releasing hormone (GnRH) agonists drugs: a case report
- Injectable Therapy for Androgenetic Alopecia: A Systematic Review
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
- Should Oral Minoxidil be Our First Choice for Treatment of Alopecia?
- ВЫБОР ТЕРАПИИ У ПАЦИЕНТОК С СИНДРОМОМ ПОЛИКИСТОЗНЫХ ЯИЧНИКОВ В ПОЗДНЕМ РЕПРОДУКТИВНОМ ВОЗРАСТЕ
- ANDROGENINĖS ALOPECIJOS MEDIKAMENTINIO GYDYMO GALIMYBĖS
- The Hormonal Background of Hair Loss in Non-Scarring Alopecias
- Synthesis and application of clinically approved small-molecule drugs targeting androgen receptor
- Androgenetic Alopecia: Therapy Update
- Polycystic ovary syndrome (multifactorial endocrinopathy): manifestation and treatment strategies
- Caractérisation physique et chimique des substances à activité thérapeutique : application aux études de profil de stabilité et de préformulation
- 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA
- 1406 DETECTION OF MEMBRANE ANDROGEN-BINDING SITE IN LIVING RAT PROSTATE AND EVALUATION OF ITS ROLE IN PROSTATE BLOOD FLOW REGULATION
- Slow progress in prostate cancer
- Female pattern hair loss: therapeutic update
- Antiandrogens
- Modulation der Hitzesensitivität im Prostatakarzinom in vitro: Der Einfluss der Androgenachse
- The challenging role of antiandrogens in the management of polycystic ovary syndrome
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- Dynamet wins titanium award
- Hormone Blocking Anticancer Drugs
- A guide to diagnosis and management of hypertrichosis
- Thiohydrazides in the Synthesis of Functionalized Extranuclear Heterosteroids
- Research progress on drug-induced gynecomastia
- 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Therapeutic Androgen Receptor Ligands
- (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production
- Pantolactams as androgen receptor antagonists for the topical suppression of sebum production
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol